Year: 2022

Credit Acceptance Announces Increase and Extension of Revolving Secured Warehouse Facility and Extension of Asset-Backed Financing

Written by Customer Service on December 27, 2022. Posted in Public Companies.

Southfield, Michigan , Dec. 27, 2022 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we increased the amount of Warehouse Facility V (the “Facility”), one of our revolving secured warehouse facilities, from $125.0 million to $200.0 million. We also extended the date on which the Facility will cease to revolve from December 18, 2023 to December 29, 2025. The maturity of the Facility was also extended from December 16, 2025 to December 27, 2027. The interest rate on borrowings under the Facility has increased from Secured Overnight Financing Rate (“SOFR”) plus 235 basis points to SOFR plus 245 basis points and the servicing fee has decreased from 6.0% to 4.0% of collections on the underlying consumer loans. As of December...

Tiziana Life Sciences Ltd (“Tiziana” or “the Company”) – Interim Results for the Six Months Ended 30 June 2022

Written by Customer Service on December 27, 2022. Posted in Public Companies.

Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet need LONDON, Dec. 27, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (“Tiziana”, NASDAQ: TLSA), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases today announces its interim results for the six months ended 30 June 2022. Highlights during the period: CLINICAL and NON-CLINICAL PROGRAMMES ForalumabTZLS-401Announced FDA approval for enrollment of a second, Secondary Progressive Multiple Sclerosis (SPMS) patient in under the Individual Patient Expanded Access (EA) Program following favorable clinical results after 6 months of treatment of the first patient in the EA program.Announced initiation of phase 1b clinical trial in Crohn’s disease patients to...

Welsbach Technology Metals Acquisition Corp. Announces Receipt of Deposit Proceeds from Extension Note

Written by Customer Service on December 27, 2022. Posted in Mergers And Acquisitions.

New York, NY, Dec. 27, 2022 (GLOBE NEWSWIRE) — Welsbach Technology Metals Acquisition Corp. (the “Company”), announced today that on December 30, 2022 it issued and sold to Welsbach Acquisition Holdings LLC (the “Sponsor”) a non-interest bearing, unsecured promissory note equal to $772,768.60 (the “Proceeds”), and that such Proceeds were placed on deposit in the Company’s Trust Account on December 23, 2022. As such, in accordance with Article G of the Company’s amended and restated certificate of incorporation, the Company’s time period to consummate a Business Combination has been extended to and including March 30, 2023. Such note would not be repaid in the event that the Company is unable to close a business combination unless there are funds available outside the trust account to do so and would either be paid upon consummation...

Masitinib receives orphan drug status for the treatment of amyotrophic lateral sclerosis in Switzerland

Written by Customer Service on December 27, 2022. Posted in Public Companies.

PRESS RELEASE MASITINIB RECEIVES ORPHAN DRUG STATUS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN SWITZERLAND Paris, December 27, 2022, 7pm CET AB Science SA (Euronext – FR0010557264 – AB) today announces that masitinib has been granted orphan drug status (ODS) by the Swiss Agency for Therapeutic Products (Swissmedic) for the treatment of patients with amyotrophic lateral sclerosis (ALS). As a reminder, masitinib has previously received ODS for ALS from the U.S. Food and Drug Administration (FDA) and from the European Medicines Agency (EMA). This designation provides the sponsor with a series of incentives, including:the possibility of a simplified authorization procedure (Art.13) by Swissmedic fee waivers, and extended document protection period of 15 years.Orphan drug designation in Switzerland is given...

Results of the Extraordinary Shareholders’ Meeting

Written by Customer Service on December 27, 2022. Posted in Public Companies.

Ghent, Belgium, Dec. 27, 2022 (GLOBE NEWSWIRE) — — Press release – regulated information Biotalys (Euronext – BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, held an extraordinary shareholders’ meeting today at 11:00 a.m. CET at the Company’s seat. The legally required presence quorum was reached for the extraordinary shareholders’ meeting. The shareholders approved all items on the agenda of the meeting. All documents relating to the shareholders’ meeting can be consulted on the website of the Company. The minutes will be made available in due course. – ENDS – For further information, please contact Toon Musschoot, Head of IR & CommunicationT: +32 (0)9 274 54 00E: Toon.Musschoot@biotalys.com About...

Ilkka Oyj – Acquisition of own shares on 27 December 2022

Written by Customer Service on December 27, 2022. Posted in Public Companies.

ILKKA OYJ, STOCK EXCHANGE RELEASE, 27 December 2022 at 19:00 EET Ilkka Oyj – Acquisition of own shares on 27 December 2022 At Nasdaq Helsinki Ltd:Date 27 December 2022Exchange transaction BuyShare trading code ILKKA2Amount, shares 1,400Average price/share, EUR 3.6197Total cost, EUR 5,067.58The company holds a total of 19,308 of its own shares (ILKKA2) including the shares acquired on 27 December 2022. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.com AttachmentIlkka buyback 27.12.2022

CORRECTION — Veeco Announces Upcoming Investor Event

Written by Customer Service on December 27, 2022. Posted in Public Companies.

PLAINVIEW, N.Y., Dec. 27, 2022 (GLOBE NEWSWIRE) — Veeco management will be on site to present and meet with investors at the Lotte New York Palace Hotel in New York City, NY. An earlier press release indicated Veeco’s participation would be virtual. Veeco Instruments Inc. (NASDAQ: VECO) today announced that management is scheduled to present at the 25th Annual Needham Growth Conference at 4:30 PM ET on Tuesday, January 10, 2023 at the Lotte New York Palace Hotel in New York City, NY. Veeco management will also be available to meet in person with investors during the conference. Interested investors should contact their Needham representative to secure a meeting time. The presentation will be broadcast live and can be accessed on the investor relations section of Veeco’s website at ir.veeco.com. A webcast replay will be made...

Rovio Entertainment Corporation: Repurchase of own shares on 27 December 2022

Written by Customer Service on December 27, 2022. Posted in Public Companies.

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 27.12.2022 at 18.45 EET Rovio Entertainment Corporation – Repurchase of own shares on 27.12.2022 Rovio Entertainment Corporation In the Nasdaq Helsinki Date 27.12.2022Exchange transaction BUYShare trading code ROVIOAmount, shares 8615Average price/share, EUR 6,089565Total cost, EUR 52461,60 Rovio now holds a total of 6 856 349 shares including the shares repurchased on 27.12.2022 On behalf of Rovio Entertainment Corporation OP Corporate Bank PLC Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Disclosure of transactions in own shares from December 19th to December 20th, 2022

Written by Customer Service on December 27, 2022. Posted in Public Companies.

Nanterre, December 27th, 2022 Disclosure of transactions in own shares From December 19th to December 20th, 2022 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 12, 2022 to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from December 19th to December 20th, 2022 : I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 19-Dec-22 FR0000125486 45 92,3700...

Social Life Network’s TBI program growing through roll-up mergers

Written by Customer Service on December 27, 2022. Posted in Public Companies.

LOS ANGELES, CA, Dec. 27, 2022 (GLOBE NEWSWIRE) — Social Life Network, Inc. (OTC: WDLF), a Technology Business Incubator (TBI) that holds a 15% stake in each of the companies that participate in its TBI program, has announced (Read press release: https://apnews.com/press-release/ein-presswire-newsmatics/business-20e3a63a7b866fd2eafd4aa20e05076d) that one of its TBI companies operating in the legalized cannabis industry, WeedLife, Inc. has executed a Letter of Intent to acquire Saving Grace Oil, Inc, a CBD company. “The business model of roll-up mergers by our TBI companies is meant to rapidly increase their bottom-line revenues, while leveraging their social networking audience to increase product and brand awareness,” said CEO, Ken Tapp. “Our focus in the TBI program during the second half of this year has been to aid companies...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals